Total Payments
$336,753
2024 Payments
$8,212
Companies
69
Transactions
1,474
Medicare Patients
1,762
Medicare Billing
$143,907
Payment Breakdown by Category
Other$243,676 (72.4%)
Food & Beverage$46,036 (13.7%)
Consulting$27,719 (8.2%)
Travel$18,892 (5.6%)
Education$430.09 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $229,526 | 178 | 68.2% |
| Food and Beverage | $46,036 | 1,096 | 13.7% |
| Consulting Fee | $27,719 | 15 | 8.2% |
| Travel and Lodging | $18,892 | 159 | 5.6% |
| Honoraria | $10,150 | 6 | 3.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 4 | 1.2% |
| Education | $430.09 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $66,792 | 159 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $50,346 | 101 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $36,175 | 82 | $0 (2021) |
| GENZYME CORPORATION | $32,956 | 111 | $0 (2024) |
| ABBVIE INC. | $31,876 | 70 | $0 (2024) |
| UCB, Inc. | $25,027 | 112 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $21,432 | 70 | $0 (2022) |
| US WorldMeds, LLC | $19,591 | 65 | $0 (2020) |
| Mallinckrodt Enterprises LLC | $9,632 | 42 | $0 (2019) |
| LivaNova USA, Inc. | $8,289 | 53 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,212 | 79 | GENZYME CORPORATION ($3,305) |
| 2023 | $21,046 | 103 | Teva Pharmaceuticals USA, Inc. ($8,036) |
| 2022 | $12,896 | 102 | Teva Pharmaceuticals USA, Inc. ($4,843) |
| 2021 | $37,113 | 182 | AbbVie Inc. ($17,283) |
| 2020 | $40,206 | 162 | Allergan, Inc. ($15,901) |
| 2019 | $33,513 | 201 | Avanir Pharmaceuticals, Inc. ($9,569) |
| 2018 | $64,054 | 254 | Sunovion Pharmaceuticals Inc. ($8,480) |
| 2017 | $119,714 | 391 | Allergan Inc. ($46,659) |
All Payment Transactions
1,474 individual payment records from CMS Open Payments — Page 1 of 59
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $31.13 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.71 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Neurology | ||||||
| 11/27/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $121.36 | General |
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.23 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $9.96 | General |
| 10/15/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 10/15/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug) | Education | In-kind items and services | $0.90 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 10/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $36.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.98 | General |
| Category: NEUROLOGY | ||||||
| 10/01/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Neuroscience | ||||||
| 09/24/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.37 | General |
| 09/23/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 09/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.11 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $134.80 | General |
| Category: Neuropsychiatry | ||||||
| 08/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Neurology | ||||||
| 08/13/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Neuroscience | ||||||
| 08/08/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $124.66 | General |
| Category: Neurology | ||||||
| 08/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $21.07 | General |
| Category: NEUROLOGY | ||||||
| 08/01/2024 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,989.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 274 | 382 | $65,988 | $30,998 |
| 2022 | 7 | 348 | 481 | $69,649 | $32,440 |
| 2021 | 8 | 532 | 707 | $85,165 | $40,427 |
| 2020 | 9 | 608 | 824 | $91,208 | $40,043 |
Total Patients
1,762
Total Services
2,394
Medicare Billing
$143,907
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 119 | $20,825 | $10,092 | 48.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 99 | $11,880 | $5,808 | 48.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 38 | $12,350 | $4,963 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 35 | 47 | $7,285 | $4,221 | 57.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,750 | $2,360 | 41.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $5,060 | $2,190 | 43.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 31 | 33 | $2,838 | $1,364 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 127 | $22,225 | $10,747 | 48.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 160 | $19,200 | $8,492 | 44.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 51 | 51 | $11,220 | $4,819 | 42.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 53 | 53 | $8,003 | $3,965 | 49.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,686 | 51.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 35 | 36 | $3,291 | $1,580 | 48.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 30 | 41 | $2,460 | $1,150 | 46.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 126 | $21,660 | $11,115 | 51.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 119 | 232 | $13,920 | $6,778 | 48.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 107 | 122 | $14,552 | $6,649 | 45.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $8,342 | $4,304 | 51.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 93 | 94 | $10,275 | $4,138 | 40.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 35 | 35 | $5,921 | $2,668 | 45.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $4,400 | $2,115 | 48.1% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 13 | $2,107 | $1,027 | 48.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 17 | 19 | $2,188 | $845.33 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 12 | $1,800 | $786.94 | 43.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 131 | $21,110 | $9,113 | 43.2% |
About Dr. David Lobas, M.D
Dr. David Lobas, M.D is a Neurology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619039534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lobas, M.D has received a total of $336,753 in payments from pharmaceutical and medical device companies, with $8,212 received in 2024. These payments were reported across 1,474 transactions from 69 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($229,526).
As a Medicare-enrolled provider, Lobas has provided services to 1,762 Medicare beneficiaries, totaling 2,394 services with total Medicare billing of $143,907. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Pittsburgh, PA
- Active Since 12/15/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619039534
Products in Payments
- NAMZARIC (Drug) $49,918
- AUSTEDO (Drug) $44,185
- UBRELVY (Drug) $39,752
- NUEDEXTA (Drug) $36,056
- APTIOM (Drug) $21,403
- Briviact (Drug) $17,478
- DISEASE STATE (Drug) $14,649
- VNS Therapy (Device) $10,733
- Xadago (Drug) $10,610
- ACTHAR (Biological) $9,980
- APOKYN (Drug) $8,573
- QULIPTA (Drug) $8,445
- Rebif (Biological) $5,592
- GOCOVRI (Drug) $5,209
- AUBAGIO (Drug) $4,447
- Austedo XR (Drug) $4,439
- Vimpat (Drug) $4,173
- Cenobamate (Drug) $1,867
- LEMTRADA (Drug) $1,013
- NURTEC ODT (Drug) $940.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Pittsburgh
Dr. Raul Nogueira, Md, MD
Neurology — Payments: $1.1M
Neurology $1.1M
Thomas Scott, Md, MD
Neurology — Payments: $785,755
Neurology $785,755
Anoopum Gupta, M.d., Ph.d, M.D., PH.D
Neurology — Payments: $726,876
Neurology $726,876
James Valeriano, Md, MD
Neurology — Payments: $469,230
Neurology $469,230
Andrea Synowiec, Do, DO
Neurology — Payments: $437,510
Neurology $437,510
Amber Van Laar
Neurology — Payments: $413,359
Neurology $413,359